← Back to Search

Other

Sunscreen for Skin Cancer

Phase 1

Waitlist Available

Led By Michael Girardi, MD, FAAD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

Study Summary

This trial tests a new sunscreen to see how well it protects people from UV radiation and the damage it can cause.

Eligible Conditions

Skin Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cellular Damage

DNA Strand Breaks

UVR Exposure

Trial Design

2Treatment groups

Experimental Treatment

Group I: SunscreenExperimental Treatment2 Interventions

Portion of skin covered by sunscreen.

Group II: No treatment controlExperimental Treatment1 Intervention

Portion of skin not covered by sunscreen.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sunscreen

2012

Completed Phase 3

~1770

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,736,498 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,123 Total Patients Enrolled

Michael Girardi, MD, FAADPrincipal InvestigatorEvans Professor of Dermatology; Director, Residency Program, Dermatology

2 Previous Clinical Trials

17 Total Patients Enrolled

Media Library

Sunscreen (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05736224 — Phase 1

Skin Cancer Research Study Groups: Sunscreen, No treatment control

Skin Cancer Clinical Trial 2023: Sunscreen Highlights & Side Effects. Trial Name: NCT05736224 — Phase 1

Sunscreen (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05736224 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA verified Sunscreen as being safe for use?

"Sunscreen has only been tested on a limited scale, so it received a score of 1. Data is still being collected to determine its efficacy and safety."

Answered by AI

Is this research endeavor currently open to recruitment?

"Evidence gleaned from clinicaltrials.gov suggests this trial is open to participants, with it having been first introduced on May 15th 2023 and amended the following day."

Answered by AI

What is the participant count for this experimental research?

"Affirmative. According to the information on clinicaltrials.gov, there is currently a recruitment drive for this medical trial which was first published on May 15th 2023 and most recently edited on 16th of the same month. The researchers are looking for 30 individuals across one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen

2023. "Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05736224.